Medicofarma Biotech Spolka Akcyjna Logo

Medicofarma Biotech Spolka Akcyjna

R&D company developing innovative medicines, medical devices, and biotech products.

MDB | WAR

Overview

Corporate Details

ISIN(s):
PLINBOK00010
LEI:
259400W39H7UHW9EJP66
Country:
Poland
Address:
Warszawa Sokołowska 9/U19, 01-142 Warszawa

Description

Medicofarma Biotech Spolka Akcyjna is a research and development company specializing in innovative medicines, medical devices, and biotechnology products. The company's core mission is to design, refine, and introduce novel pharmacological solutions that address critical unmet medical needs, with a particular focus on the prevention and treatment of civilization diseases. Through its dedicated R&D Center, the company collaborates with scientific institutions and manufacturing partners, providing support in areas such as pre-formulation for generic and cosmetic products. Key research areas include the development of therapies for oncology and oral diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-18 18:43
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
Polish 1.3 KB
2024-03-06 19:35
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 3.3 KB
2024-01-03 22:51
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
Polish 1.7 KB
2024-01-02 17:16
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
Polish 4.5 KB
2023-12-31 19:41
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 2.1 KB
2023-12-31 19:33
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
Polish 2.9 KB
2023-12-31 19:24
Strategia na lata 2024-2026
Polish 2.6 MB
2023-12-31 19:24
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
Polish 1.8 KB
2023-10-26 22:42
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
Polish 2.5 KB
2023-10-23 20:42
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
Polish 6.3 KB
2023-10-11 21:07
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
Polish 1.9 KB
2023-07-20 19:38
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
Polish 1.2 KB
2023-07-19 18:01
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
Polish 716 bytes
2023-06-30 22:59
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 766 bytes
2023-06-02 15:22
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
Polish 345.3 KB

Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicofarma Biotech Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NANO MRNA Co.,Ltd. Logo
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
Japan
4571
NANOVIRICIDES, INC. Logo
Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.
United States of America
NNVC
Nautilus Biotechnology, Inc. Logo
Develops a proteome analysis platform to quantify proteins at the single-molecule level.
United States of America
NAUT
NeoImmuneTech, Inc. Logo
A clinical-stage biopharma developing T cell-focused immuno-therapeutics for diseases.
United States of America
950220
Neovacs Logo
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
France
ALNEV
NewAmsterdam Pharma Co N.V. Logo
A clinical-stage biopharma developing therapies for metabolic diseases with unmet needs.
United States of America
NAMS
NextGen Biomed Ltd. Logo
Develops novel therapeutic delivery systems and pain-free auto-injectors.
Israel
NXGN
NEXTURNBIOSCIENCE Co., LTD Logo
Manufacturer of CNC automatic lathes and ultra-precision components for various industries.
South Korea
089140
NFL Biosciences Logo
Biopharmaceutical company developing botanical drug candidates for addiction treatment.
France
ALNFL
NGeneBio Co., Ltd. Logo
Develops NGS-based molecular diagnostic products and software for oncology.
South Korea
354200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.